bioRxivCell BiologyPreprint
Dynamic interactions and intracellular fate of label-free GO within mammalian cells: role of lateral sheet size
Y. Chen, J. Rivers-Auty, L. E. Crica, V. Rosano, A. E. Arranz, T. Loret, D. Spiller, C. Bussy, K. Kostarelos, S. Vranic
Abstract
Graphene oxide (GO) holds great potential for biomedical applications, however fundamental understanding of the way it interacts with biological systems is still lacking even though it is essential for successful clinical translation. In this study, we exploit intrinsic fluorescent properties of thin GO sheets to establish the relationship between lateral dimensions of the material, its cellular uptake mechanisms and intracellular fate over time. Label-free GO with distinct lateral dimensions, small (s-GO) and ultra-small (us-GO) were thoroughly characterised both in water and in biologically relevant cell culture medium. Interactions of the material with a range of non-phagocytic mammalian cell lines (BEAS-2B, NIH/3T3, HaCaT, 293T) were studied using a combination of complementary analytical techniques (confocal microscopy, flow cytometry and TEM). The uptake mechanism was initially interrogated using a range of pharmaceutical inhibitors and validated using polystyrene beads of different diameters (0.1 and 1 m). Subsequently, RNA-Seq was used to follow the changes in the uptake mechanism used to internalize s-GO flakes over time. Regardless of lateral dimensions, both types of GO were found to interact with the plasma membrane and to be internalized by a panel of cell lines studied. However, s-GO was internalized mainly via macropinocytosis while us-GO was mainly internalized via clathrin- and caveolae-mediated endocytosis. Importantly, we report the shift from macropinocytosis to clathrin-dependent endocytosis in the uptake of s-GO at 24 h, mediated by upregulation of mTORC1/2 pathway. Finally, we show that both s-GO and us-GO terminate in lysosomal compartments for up to 48 h. Our results offer an insight into the mechanism of interaction of GO with non-phagocytic cell lines over time that can be exploited for the design of biomedically-applicable 2D transport systems.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interplay between material properties and cellular effects drives distinct pattern of interaction of graphene oxide with cancer and non-cancer cells
Yingxian Chen, Vinicio Rosano, … Sandra Vranic·Journal of NanobiotechnologyPeer-reviewed·May 29, 2025
- Plasma membrane-associated graphene oxide as aplatform for modulating signalling through cell-surfacereceptors: an integrin-focused proof-of-concept study
Michael A. Karakassides, Neus Lozano, … Sandra Vranic·bioRxiv·Aug 26, 2026
- Graphene-enabled, spatially controlled electroporation of adherent cells for live-cell super-resolution microscopy
- Fluorescent Chiral Quantum Dots to Unveil Origin-Dependent Exosome Uptake and Cargo Release
- Graphene Oxide as 2D Platform for Complexation and Intracellular Delivery of siRNA
I. de Lazaro, S. Vranic, … K. Kostarelos·bioRxiv·Dec 4, 2018
- Insights into gadolinium uptake and release dynamics of a macrocyclic contrast agent in blood cells
A Rivera Gómez, Nathalie Peyer, … Nico O. Ruprecht·bioRxiv·Jul 8, 2026